Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Reardon

Showing results (491-500 of 558) with videos related to

Pageof 56
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 18, 2024
Redo-TAVI with the SAPIEN 3 valve in degenerated calcified CoreValve/Evolut explantsDavid Meier, Anish Nigade, Althea Lai, et al.
JAMA Network Open|October 27, 2022
Long-term Outcomes of Transcatheter Aortic Valve Replacement With the Lotus Valve vs CoreValve/EvolutR: A Secondary Analysis of the REPRISE III Randomized Clinical TrialDavid G Rizik, Vivek Rajagopal, Raj R Makkar, et al.
Echocardiography (Mount Kisco, N.Y.)|December 3, 2024
Core Laboratory Versus Center-Reported Echocardiographic Assessment of the Native and Bioprosthetic Aortic ValveBart J J Velders, Michiel D Vriesendorp, Neil J Weissman, et al.
JACC. Cardiovascular Interventions|April 24, 2024
Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk PatientsNeal S Kleiman, Nicolas M Van Mieghem, Michael J Reardon, et al.
JACC. Cardiovascular Interventions|August 22, 2015
Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal TrialSuzanne V Arnold, Matthew R Reynolds, Kaijun Wang, et al.
The Annals of Thoracic Surgery|January 9, 2018
Impact of Annular Size on Outcomes After Surgical or Transcatheter Aortic Valve ReplacementG Michael Deeb, Stanley J Chetcuti, Steven J Yakubov, et al.
JACC. Cardiovascular Interventions|November 8, 2021
30-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study ResultsFiras Zahr, Howard K Song, Scott M Chadderdon, et al.
Circulation|April 4, 2022
Quality of Life After Fractional Flow Reserve-Guided PCI Compared With Coronary Bypass SurgeryWilliam F Fearon, Frederik M Zimmermann, Victoria Y Ding, et al.
JACC. Cardiovascular Interventions|March 11, 2022
Propensity-Matched 1-Year Outcomes Following Transcatheter Aortic Valve Replacement in Low-Risk Bicuspid and Tricuspid PatientsG Michael Deeb, Michael J Reardon, Basel Ramlawi, et al.
JACC. Cardiovascular Interventions|July 24, 2024
3-Year Outcomes From the Evolut Low Risk TAVR Bicuspid StudyFiras Zahr, Basel Ramlawi, Michael J Reardon, et al.
Pageof 56

Showing results (491-500 of 558) with videos related to

Sort By:
Pageof 56
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 18, 2024
Redo-TAVI with the SAPIEN 3 valve in degenerated calcified CoreValve/Evolut explantsDavid Meier, Anish Nigade, Althea Lai, et al.
JAMA Network Open|October 27, 2022
Long-term Outcomes of Transcatheter Aortic Valve Replacement With the Lotus Valve vs CoreValve/EvolutR: A Secondary Analysis of the REPRISE III Randomized Clinical TrialDavid G Rizik, Vivek Rajagopal, Raj R Makkar, et al.
Echocardiography (Mount Kisco, N.Y.)|December 3, 2024
Core Laboratory Versus Center-Reported Echocardiographic Assessment of the Native and Bioprosthetic Aortic ValveBart J J Velders, Michiel D Vriesendorp, Neil J Weissman, et al.
JACC. Cardiovascular Interventions|April 24, 2024
Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk PatientsNeal S Kleiman, Nicolas M Van Mieghem, Michael J Reardon, et al.
JACC. Cardiovascular Interventions|August 22, 2015
Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal TrialSuzanne V Arnold, Matthew R Reynolds, Kaijun Wang, et al.
The Annals of Thoracic Surgery|January 9, 2018
Impact of Annular Size on Outcomes After Surgical or Transcatheter Aortic Valve ReplacementG Michael Deeb, Stanley J Chetcuti, Steven J Yakubov, et al.
JACC. Cardiovascular Interventions|November 8, 2021
30-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study ResultsFiras Zahr, Howard K Song, Scott M Chadderdon, et al.
Circulation|April 4, 2022
Quality of Life After Fractional Flow Reserve-Guided PCI Compared With Coronary Bypass SurgeryWilliam F Fearon, Frederik M Zimmermann, Victoria Y Ding, et al.
JACC. Cardiovascular Interventions|March 11, 2022
Propensity-Matched 1-Year Outcomes Following Transcatheter Aortic Valve Replacement in Low-Risk Bicuspid and Tricuspid PatientsG Michael Deeb, Michael J Reardon, Basel Ramlawi, et al.
JACC. Cardiovascular Interventions|July 24, 2024
3-Year Outcomes From the Evolut Low Risk TAVR Bicuspid StudyFiras Zahr, Basel Ramlawi, Michael J Reardon, et al.
Pageof 56